Global Market Watch:
Global biochips market is forecasted to reach US$9.1 billion by 2015 with a CAGR of 20.9% during 2009-2015; the massive CAGR is primarily supported by Asia-Pacific followed by the European Union. Among the major industry segments, biochips instruments are expected to exert the highest support to the industry with a CAGR of 22.6% globally. Microarrays segment accounts for nearly 60% of the industry value while instruments, reagents and consumables together indicate approximately 25% of the market value. North America is expected to maintain the highest market share for the biochips industry by 2015; Asian economies are expected to post a large CAGR of 23 percent during 2009-2015. Higher growth rate favors improved industry investments in Asia-Pacific region in comparison with North America and Europe, going ahead.
The report ‘Biochips - Products, Applications, Technologies And End-Use Markets Growth Analysis, 2009-2015’ reviews the latest biochips market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations. The report primarily focuses on:
- Emerging Market Trends
- Advancements in the Technological Space
- Market Demand Of The Segments (By-Region)
- Key Growth Areas and Market Size
- Region-Wise Demand Factor
- Key Competitors Edge
- Investment Strategies
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the biochips industry. Anticipating a protracted recovery towards 2011, we have used CAGR to forecast 2011-2015 figures.
The analysis primarily deals with products, applications, technologies and end-use markets. Further, the subdivided categories include:
Biochips Products Microarrays
- DNA Microarrays
- Lab-On-Chips (LOC)
- Protein Microarrays
- Cell-On-Chips (COC)
- Others Microarrays (Tissue Microarrays, Chemical Microarrays, Drugs of Abuse (DOA) Arrays & Others)
- Detection Instrument
- Production Instrument
- Sample Preparation & Hybridization Instruments
Reagents & Consumables
- Extraction Reagents
- Labeling Kits
- Drug Discovery & Development
- In-Vitro Diagnostics
- Research And Development
- Forensic Sciences
- Others (Disease Detection, Drugs Testing, Agriculture, Industrial &, Environmental Applications)
- Gene Expression
- SNP Identification & Genotyping
- DNA Structuring
- Protein Structuring
- Microfluidics Technology
- Others (Photolithography, Samples Preparation & Hybridization Processes, Data Analysis, Detection Technologies, Research Technologies)
Biochips End-Use Markets
- Defense & Military (Government Agencies)
- Others (Academic, Therapeutics, Health, Environment and Food Control)
The period considered for the biochips market analysis is 2009-2015. The region wise distribution of the market consists of North America (USA and Canada), Europe (Germany, France, United Kingdom, Italy, Spain and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, Australia and Rest of Asia-Pacific) and Rest of the World. Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.
More than 600 leading market players are identified and 50 key companies that project improved market activities in the near future are profiled. The report consists of 449 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
The evolution of biochips has opened new vistas in the biological systems. In addition, all other sciences are integrated which cumulatively contribute for a big future for biochip industry. The broad ‘life science’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. Accelerating growth rate exhibited by the biochips industry, even during the recession years, confirms the positive growth prospects going ahead. The field of drug research gets more glamorous with the drug screening at cellular level. DNA microarrays and biochips have created revolution enabling the target validation and drug discovery. Genome scan is very soon going to become an ultimate weapon for diagnosis. In no time all the information related to genes will be sequenced, annotated and completed along with the list of diseases which are susceptible. Day to day the researchers are also making an effort to develop medication to control the various diseases, by using biochip technology. As the applications of biochips are wide both in the research and clinical use, a wide potential market is expected. The emergence of biochip technology can be attributed to a decade which has gradually developed into maturity. This industry is expected to bring rapid and significant changes in the life sciences and medicine. Microarray technology has a great potential and is widely used in DNA and protein analysis.